Guardian Pharmacy Revenue and Competitors

Markham, ON CAN

Location

N/A

Total Funding

Retail

Industry

Estimated Revenue & Valuation

  • Guardian Pharmacy's estimated annual revenue is currently $113.2M per year.(i)
  • Guardian Pharmacy's estimated revenue per employee is $335,953

Employee Data

  • Guardian Pharmacy has 337 Employees.(i)
  • Guardian Pharmacy grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4M14-30%N/AN/A
#2
$53.7M1869%N/AN/A
#3
$67.7M28213%N/AN/A
#4
$318.4M1002N/AN/AN/A
#5
$13.1M6436%N/AN/A
#6
$7.8M340%N/AN/A
#7
$86.5M2493%N/AN/A
#8
$1.9M1330%N/AN/A
#9
$27.2M120N/AN/AN/A
#10
N/A3934%N/AN/A
Add Company

Independently owned and operated since 1964, Guardian® pharmacies are run by pharmacists who pride themselves on keeping their communities healthy.

keywords:N/A

N/A

Total Funding

337

Number of Employees

$113.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Guardian Pharmacy News

2022-04-20 - Manslaughter conviction for mother of seven-year-old who died ‘gasping for air’

His body was found the next morning and there was no sign of his asthma medication being with him. Pharmacy records revealed that in the last...

2022-04-20 - Manslaughter conviction for mother of seven-year-old who died ‘gasping for air’

His body was found the next morning and there was no sign of his asthma medication being with him. Pharmacy records revealed that in the last...

2022-04-20 - The Guardian view on Boris Johnson in India: flying into trouble

Britain's prime minister pointedly described India as the world's pharmacy. Mr Johnson, who faces political oblivion thanks to his own...

2022-04-20 - The Guardian view on Boris Johnson in India: flying into trouble

Britain's prime minister pointedly described India as the world's pharmacy. Mr Johnson, who faces political oblivion thanks to his own...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$107.3M3593%N/A
#2
$112.8M3781%N/A
#3
$144.1M38910%N/A
#4
$129.3M4167%N/A
#5
$179.6M4500%N/A